DE50203521D1 - MEDICINAL FORMULATION CONTAINING AN LTB4 ANTAGONIST AND A NETWORK - Google Patents
MEDICINAL FORMULATION CONTAINING AN LTB4 ANTAGONIST AND A NETWORKInfo
- Publication number
- DE50203521D1 DE50203521D1 DE50203521T DE50203521T DE50203521D1 DE 50203521 D1 DE50203521 D1 DE 50203521D1 DE 50203521 T DE50203521 T DE 50203521T DE 50203521 T DE50203521 T DE 50203521T DE 50203521 D1 DE50203521 D1 DE 50203521D1
- Authority
- DE
- Germany
- Prior art keywords
- network
- formulation containing
- medicinal formulation
- ltb4 antagonist
- ltb4
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE50203521T DE50203521D1 (en) | 2001-07-14 | 2002-07-09 | MEDICINAL FORMULATION CONTAINING AN LTB4 ANTAGONIST AND A NETWORK |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10134377 | 2001-07-14 | ||
| DE10206241A DE10206241A1 (en) | 2001-07-14 | 2002-02-15 | Drug formulation containing an LTB antagonist |
| DE50203521T DE50203521D1 (en) | 2001-07-14 | 2002-07-09 | MEDICINAL FORMULATION CONTAINING AN LTB4 ANTAGONIST AND A NETWORK |
| PCT/EP2002/007618 WO2003007922A2 (en) | 2001-07-14 | 2002-07-09 | Pharmaceutical formulation containing an ltb4 antagonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE50203521D1 true DE50203521D1 (en) | 2005-08-04 |
Family
ID=7691857
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE10206241A Withdrawn DE10206241A1 (en) | 2001-07-14 | 2002-02-15 | Drug formulation containing an LTB antagonist |
| DE50203521T Expired - Fee Related DE50203521D1 (en) | 2001-07-14 | 2002-07-09 | MEDICINAL FORMULATION CONTAINING AN LTB4 ANTAGONIST AND A NETWORK |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE10206241A Withdrawn DE10206241A1 (en) | 2001-07-14 | 2002-02-15 | Drug formulation containing an LTB antagonist |
Country Status (6)
| Country | Link |
|---|---|
| AR (1) | AR036339A1 (en) |
| CO (1) | CO5560535A2 (en) |
| DE (2) | DE10206241A1 (en) |
| PE (1) | PE20030255A1 (en) |
| SA (1) | SA03230511A (en) |
| ZA (1) | ZA200309710B (en) |
-
2002
- 2002-02-15 DE DE10206241A patent/DE10206241A1/en not_active Withdrawn
- 2002-07-09 DE DE50203521T patent/DE50203521D1/en not_active Expired - Fee Related
- 2002-07-12 AR ARP020102604A patent/AR036339A1/en not_active Suspension/Interruption
- 2002-07-12 PE PE2002000623A patent/PE20030255A1/en not_active Application Discontinuation
-
2003
- 2003-01-13 SA SA03230511A patent/SA03230511A/en unknown
- 2003-12-15 ZA ZA200309710A patent/ZA200309710B/en unknown
-
2004
- 2004-02-10 CO CO04010954A patent/CO5560535A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR036339A1 (en) | 2004-09-01 |
| CO5560535A2 (en) | 2005-09-30 |
| PE20030255A1 (en) | 2003-04-22 |
| SA03230511A (en) | 2005-12-03 |
| ZA200309710B (en) | 2004-06-04 |
| DE10206241A1 (en) | 2003-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20033384D0 (en) | Pharmaceutical formulation | |
| ITTO20010008A0 (en) | PHARMACEUTICAL FORMULATION | |
| NO20033785D0 (en) | Pharmaceutical formulation | |
| EP1367060A4 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof | |
| EP1364957A4 (en) | Glycopyranosyloxypyrazole derivatives and medicinal use thereof | |
| EP1364958A4 (en) | Glycopyranosyloxypyrazole derivatives and medicinal use thereof | |
| HUP0002316A3 (en) | Flash-melt oral dosage formulation | |
| FIU20000164U0 (en) | A new pharmaceutical formulation | |
| GB0118689D0 (en) | Pharmaceutical formulation | |
| NO20035627D0 (en) | Pharmaceutical formulation | |
| GB0108470D0 (en) | Pharmaceutical compositions and their use | |
| HUP0500638A3 (en) | Flashmelt oral dosage formulation | |
| NO20041485L (en) | Pharmaceutical formulation comprising (R) -bicalutamide | |
| PT1272499E (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING OLIGOSACARIDES AND THEIR PREPARATION | |
| FR2820311B3 (en) | PORTABLE DRUG DISPENSER | |
| AR025867A1 (en) | PHARMACEUTICAL PORTASDORA FORMULATION | |
| NO20004816D0 (en) | New pharmaceutical formulation | |
| DE50203521D1 (en) | MEDICINAL FORMULATION CONTAINING AN LTB4 ANTAGONIST AND A NETWORK | |
| GB0104749D0 (en) | Pharmaceutical formulation | |
| NO20041236L (en) | Pharmaceutical Formulation | |
| SE0101171D0 (en) | Pharmaceutical formulation | |
| SE0103565D0 (en) | Pharmaceutical formulation | |
| SE0102572D0 (en) | Pharmaceutical formulation | |
| SE0102069D0 (en) | Pharmaceutical formulation | |
| SE0101326D0 (en) | Pharmaceutical formulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |